NCT00921635暂停3 期
A Phase III Study to Evaluate the Impact of Maintaining Haemoglobin Levels Above 120g/L Verses Above 100g/L in Anaemic Patients With Carcinoma of the Cervix Receiving Concurrent Cisplatin and Radiation Therapy
适应症
试验速览
- 阶段
- 3 期
- 状态
- 暂停
- 入组人数
- 2
- 主要终点
- The impact of maintaining hemoglobin levels above 120 g/L versus above 100 g/L
研究概览
简要总结
The purpose of this study is to assess the feasibility, safety and short term effects on health related quality of life, of maintaining hemoglobin from 120 to 130 g/L versus from 100 to 110 g/L, with red cell concentrate (RCC) transfusion, in women having chemo-radiation for cancer of the cervix.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Previously untreated cervix cancer
- •FIGO stage IB2, II, IIIB, IVA
- •Suitable for treatment with radical intent using concurrent cisplatin and pelvic radiation
排除标准
- •Hemoglobin level above 125g/L
- •Lower one-third vaginal involvement
- •Para-aortic lymphadenopathy
结局指标
主要结局
The impact of maintaining hemoglobin levels above 120 g/L versus above 100 g/L
时间窗: 5 years
次要结局
未报告次要终点
研究者
相似试验
已完成
3 期
Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831Schizophreniform DisorderSchizophreniaBipolar I DisorderNCT03201757Alkermes, Inc.524
终止
3 期
Study to Evaluate Broadlumab vs Placebo and UstekinumabPsoriasisNCT02786732MedDerm Associates15
已完成
3 期
Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS)EpilepsyNCT01336621GlaxoSmithKline98
已完成
3 期
Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 CoinfectionHepatitis C Virus InfectionNCT02480712Gilead Sciences107
撤回
3 期
X-Ray Study Investigating The Safety And Efficacy Of SD-6010 In Subjects With Osteoarthritis Of The KneeKnee OsteoarthritisNCT01438918Pfizer
